Back to search
Previous page
NB! Don't use browsers BACK button!


Application data:

Application number: P200200607
Patent number:  
PCT application number: EP01/04783
Filing date of the application: 27.04.2001
Publication date: 15.04.2004
Date of the grant of the patent:
Priority date: 28.04.2000
20.01.2001
Estonian title :    2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
English title :    2-acyl indol derivatives and their use as anti-tumour agents
Status: Application withdrawn, deemed to be withdrawn or rejected
Fees paid for the years of validity :
IPC class: C07D209/12
C07D403/06
C07D209/14
C07D487/04
C07D403/04
A61K31/40
A61K31/44
A61K31/47
A61K31/435
A61P35/00
CPC class:
Estonian abstract: Leiutis käsitleb uusi üldvalemiga (I) indool- ja heteroindoolderivaate, nende tautomeere, stereoisomeere, nende segusid ja sooli, nende valmistamist ning üldvalemiga (I) indoolderivaatide kasutamist ravimitena.
English abstract: The invention relates to novel indol and heteroindol derivatives of the general formula (I), to their tautomers, stereoisomers, their mixtures and their salts, to the production thereof and to the use of indol derivatives of the general formula (I) as medicaments.
Applicant/holder: Baxter Healthcare SA
Inventor name: Thomas  Beckers (DE)
Silke  Baasner (DE)
Thomas  Klenner (DE)
Siavosh  Mahboobi (DE)
Herwig  Pongratz (DE)
Markus  Frieser (DE)
Harald  Hufsky (DE)
Jörg  Hockemeyer (DE)
Heinz-Herbert  Fiebig (DE)
Angelika  Burger (DE)
Frank-D  Böhmer (DE)
Drawing(s):
Click on the drawing to display a larger drawing!
Published patent application: Display the published patent application (Document A)
Patent attorney: Jaak Ostrat
   
Display: DATA OF THE FEES
 
Back to search
Previous page